Literature DB >> 16326981

Activating FLT3 mutations in CD4+/CD8- pediatric T-cell acute lymphoblastic leukemias.

Pieter Van Vlierberghe, Jules P P Meijerink, Ronald W Stam, Wendy van der Smissen, Elisabeth R van Wering, H Berna Beverloo, Rob Pieters.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16326981     DOI: 10.1182/blood-2005-06-2267

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  13 in total

1.  Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia.

Authors:  Sandra Heesch; Nicola Goekbuget; Andrea Stroux; Jutta Ortiz Tanchez; Cornelia Schlee; Thomas Burmeister; Stefan Schwartz; Olga Blau; Ulrich Keilholz; Antonia Busse; Dieter Hoelzer; Eckhard Thiel; Wolf-Karsten Hofmann; Claudia D Baldus
Journal:  Haematologica       Date:  2010-04-30       Impact factor: 9.941

Review 2.  The molecular basis of T cell acute lymphoblastic leukemia.

Authors:  Pieter Van Vlierberghe; Adolfo Ferrando
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

3.  Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.

Authors:  Ester Mejstrikova; Jana Volejnikova; Eva Fronkova; Katerina Zdrahalova; Tomas Kalina; Jaroslav Sterba; Yahia Jabali; Vladimir Mihal; Bohumir Blazek; Zdena Cerna; Daniela Prochazkova; Jiri Hak; Zuzana Zemanova; Marie Jarosova; Alexandra Oltova; Petr Sedlacek; Jiri Schwarz; Jan Zuna; Jan Trka; Jan Stary; Ondrej Hrusak
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

4.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

Authors:  Jinghui Zhang; Li Ding; Linda Holmfeldt; Gang Wu; Sue L Heatley; Debbie Payne-Turner; John Easton; Xiang Chen; Jianmin Wang; Michael Rusch; Charles Lu; Shann-Ching Chen; Lei Wei; J Racquel Collins-Underwood; Jing Ma; Kathryn G Roberts; Stanley B Pounds; Anatoly Ulyanov; Jared Becksfort; Pankaj Gupta; Robert Huether; Richard W Kriwacki; Matthew Parker; Daniel J McGoldrick; David Zhao; Daniel Alford; Stephen Espy; Kiran Chand Bobba; Guangchun Song; Deqing Pei; Cheng Cheng; Stefan Roberts; Michael I Barbato; Dario Campana; Elaine Coustan-Smith; Sheila A Shurtleff; Susana C Raimondi; Maria Kleppe; Jan Cools; Kristin A Shimano; Michelle L Hermiston; Sergei Doulatov; Kolja Eppert; Elisa Laurenti; Faiyaz Notta; John E Dick; Giuseppe Basso; Stephen P Hunger; Mignon L Loh; Meenakshi Devidas; Brent Wood; Stuart Winter; Kimberley P Dunsmore; Robert S Fulton; Lucinda L Fulton; Xin Hong; Christopher C Harris; David J Dooling; Kerri Ochoa; Kimberly J Johnson; John C Obenauer; William E Evans; Ching-Hon Pui; Clayton W Naeve; Timothy J Ley; Elaine R Mardis; Richard K Wilson; James R Downing; Charles G Mullighan
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

Review 5.  Prognostification of ALL by Cytogenetics.

Authors:  Ansar Hakeem; Aejaz Aziz Shiekh; Gull Mohd Bhat; A R Lone
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-11       Impact factor: 0.900

6.  Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors.

Authors:  Pia Riemke; Melinda Czeh; Josephine Fischer; Carolin Walter; Saeed Ghani; Matthias Zepper; Konstantin Agelopoulos; Stephanie Lettermann; Marie L Gebhardt; Nancy Mah; Andre Weilemann; Michael Grau; Verena Gröning; Torsten Haferlach; Dido Lenze; Ruud Delwel; Marco Prinz; Miguel A Andrade-Navarro; Georg Lenz; Martin Dugas; Carsten Müller-Tidow; Frank Rosenbauer
Journal:  EMBO J       Date:  2016-08-29       Impact factor: 11.598

7.  Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia.

Authors:  Pieter Van Vlierberghe; Alberto Ambesi-Impiombato; Kim De Keersmaecker; Michael Hadler; Elisabeth Paietta; Martin S Tallman; Jacob M Rowe; Carles Forne; Montserrat Rue; Adolfo A Ferrando
Journal:  Blood       Date:  2013-05-17       Impact factor: 22.113

8.  PHF6 mutations in adult acute myeloid leukemia.

Authors:  P Van Vlierberghe; J Patel; O Abdel-Wahab; C Lobry; C V Hedvat; M Balbin; C Nicolas; A R Payer; H F Fernandez; M S Tallman; E Paietta; A Melnick; P Vandenberghe; F Speleman; I Aifantis; J Cools; R Levine; A Ferrando
Journal:  Leukemia       Date:  2010-10-29       Impact factor: 11.528

9.  ETV6 mutations in early immature human T cell leukemias.

Authors:  Pieter Van Vlierberghe; Alberto Ambesi-Impiombato; Arianne Perez-Garcia; J Erika Haydu; Isaura Rigo; Michael Hadler; Valeria Tosello; Giusy Della Gatta; Elisabeth Paietta; Janis Racevskis; Peter H Wiernik; Selina M Luger; Jacob M Rowe; Montserrat Rue; Adolfo A Ferrando
Journal:  J Exp Med       Date:  2011-12-12       Impact factor: 14.307

10.  FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.

Authors:  Martin Neumann; Ebru Coskun; Lars Fransecky; Liliana H Mochmann; Isabelle Bartram; Nasrin Farhadi Sartangi; Sandra Heesch; Nicola Gökbuget; Stefan Schwartz; Christian Brandts; Cornelia Schlee; Rainer Haas; Ulrich Dührsen; Martin Griesshammer; Hartmut Döhner; Gerhard Ehninger; Thomas Burmeister; Olga Blau; Eckhard Thiel; Dieter Hoelzer; Wolf-Karsten Hofmann; Claudia D Baldus
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.